NewAmsterdam Pharma N.V. (NAMS)
NASDAQ: NAMS
· Real-Time Price · USD
25.06
-0.11 (-0.44%)
At close: Aug 15, 2025, 3:59 PM
25.07
0.04%
After-hours: Aug 15, 2025, 04:04 PM EDT
NewAmsterdam Pharma Revenue
NewAmsterdam Pharma reported an annual revenue of $45.56M, reflecting a 257% growth. For the quarter ending June 30, 2025, NewAmsterdam Pharma generated $19.14M in revenue.
Revenue (ttm)
45.56M
Revenue Growth
257%
Price / Sales Ratio
53.22
Revenue / Employee
670.04K
Employees
68
Market Cap
2.82B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|